Document Type

Dissertation

Degree

Doctor of Nursing Practice

Major

Nursing

Date of Defense

11-3-2025

Graduate Advisor

Jinnie Tkach DNP, APRN, CPNP-AC, College of Nursing

Committee

Paula Prouhet PhD, RN, CHSE

Lynelle Hinden, DC, DNP, FNP-BC

Abstract

Increasing Pediatric HPV Vaccination Rates

Abstract

Problem: The human papillomavirus (HPV) is a sexually transmitted infection that affects more than 80% of the population within the United States (Eisenhauer et al., 2020). HPV can develop into cervical, anogenital, and oropharyngeal cancers (Eisenhauer et al., 2020). About 4,000 individuals die from cervical cancer alone each year (O’Leary, 2022). The HPV vaccine, though recommended by the ACIP and AAP, is below national vaccination rates in comparison to other vaccines (O’Leary, 2022).

Methods: This quality improvement project is a non-randomized controlled trial that observed HPV vaccine dose completion rates for patients aged 9-14 at a community clinic in St. Louis, Missouri. The intervention included a patient reminder SMS message sent through an application called Doximity to remind patients their second dose (completion) dose of the HPV vaccine was due. Information collected from the intervention included how many appointments were made for the receival of the vaccine and how many patients received the completion dose of the HPV vaccine.

Results: A total of eight patients were eligible for the quality improvement intervention. Throughout the three-month intervention period between March 24th to June 24th, 2025, no patients in the sample were observed to have received the completion dose of the HPV vaccine (n = 0). As no participants produced a response from the intervention, no inferential statistical testing could be performed.

Implications for practice: More studies and quality improvement projects are needed to determine the appropriate method of increasing HPV vaccination compliance to the recommended 80% that Healthy People 2020 recommend (Eisenhauer et al., 2021).

Share

COinS